Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 394

1.

CFTR constrains the differentiation from mouse embryonic stem cells to intestine lineage cells.

Li P, Singh J, Sun Y, Ma X, Yuan P.

Biochem Biophys Res Commun. 2019 Mar 5;510(2):322-328. doi: 10.1016/j.bbrc.2019.01.100. Epub 2019 Jan 28.

PMID:
30704755
2.

Motility, Biofilm Formation and Antimicrobial Efflux of Sessile and Planktonic Cells of Achromobacter xylosoxidans.

Nielsen SM, Penstoft LN, Nørskov-Lauritsen N.

Pathogens. 2019 Jan 27;8(1). pii: E14. doi: 10.3390/pathogens8010014.

3.

Lung Transplantation as Successful Treatment of End-stage Idiopathic Pleuroparenchymal Fibroelastosis: A Case Report.

Righi I, Morlacchi L, Rossetti V, Mendogni P, Palleschi A, Tosi D, Pieropan S, Del Gobbo A, Nosotti M.

Transplant Proc. 2019 Jan - Feb;51(1):235-238. doi: 10.1016/j.transproceed.2018.04.071. Epub 2018 Jun 28.

PMID:
30655147
4.

Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.

Mangiaterra G, Amiri M, Di Cesare A, Pasquaroli S, Manso E, Cirilli N, Citterio B, Vignaroli C, Biavasco F.

BMC Infect Dis. 2018 Dec 27;18(1):701. doi: 10.1186/s12879-018-3612-9.

5.

Cystic Fibrosis: Advancing Along the Continuum.

Bono-Neri F, Romano C, Isedeh A.

J Pediatr Health Care. 2018 Oct 24. pii: S0891-5245(18)30362-6. doi: 10.1016/j.pedhc.2018.08.008. [Epub ahead of print]

PMID:
30529125
6.

The afc antifungal activity cluster, which is under tight regulatory control of ShvR, is essential for transition from intracellular persistence of Burkholderia cenocepacia to acute pro-inflammatory infection.

Gomes MC, Tasrini Y, Subramoni S, Agnoli K, Feliciano JR, Eberl L, Sokol P, O'Callaghan D, Vergunst AC.

PLoS Pathog. 2018 Dec 4;14(12):e1007473. doi: 10.1371/journal.ppat.1007473. eCollection 2018 Dec.

7.

How Do Youth with Cystic Fibrosis Perceive Their Readiness to Transition to Adult Healthcare Compared to Their Caregivers' Views?

Lapp V, Chase SK.

J Pediatr Nurs. 2018 Nov - Dec;43:104-110. doi: 10.1016/j.pedn.2018.09.012. Epub 2018 Sep 28.

PMID:
30473151
8.

Caseworker-assigned discharge plans to prevent hospital readmission for acute exacerbations in children with chronic respiratory illness.

Hall KK, Petsky HL, Chang AB, O'Grady KF.

Cochrane Database Syst Rev. 2018 Nov 2;11:CD012315. doi: 10.1002/14651858.CD012315.pub2. Review.

PMID:
30387126
9.

Elimination of Australian epidemic strain (AES1) pseudomonas aeruginosa in a pediatric cystic fibrosis center.

Kevat A, Carzino R, Massie J, Harrison J, Griffiths AL.

Pediatr Pulmonol. 2018 Nov;53(11):1498-1503. doi: 10.1002/ppul.24173. Epub 2018 Oct 12.

PMID:
30311750
10.

Cryo-EM Visualization of an Active High Open Probability CFTR Anion Channel.

Fay JF, Aleksandrov LA, Jensen TJ, Cui LL, Kousouros JN, He L, Aleksandrov AA, Gingerich DS, Riordan JR, Chen JZ.

Biochemistry. 2018 Oct 30;57(43):6234-6246. doi: 10.1021/acs.biochem.8b00763. Epub 2018 Oct 16.

PMID:
30281975
11.

Cost-effectiveness analysis of lumacaftor and ivacaftor combination for the treatment of patients with cystic fibrosis in the United States.

Sharma D, Xing S, Hung YT, Caskey RN, Dowell ML, Touchette DR.

Orphanet J Rare Dis. 2018 Sep 29;13(1):172. doi: 10.1186/s13023-018-0914-3.

12.

[Biliary atresia and congenital cholestatic syndromes : Characteristics before, after and during transition].

Junge N, Dingemann J, Petersen C, Manns MP, Richter N, Klempnauer J, Baumann U, Schneider A.

Internist (Berl). 2018 Nov;59(11):1146-1156. doi: 10.1007/s00108-018-0506-2. Review. German.

PMID:
30264190
13.

Towards measuring growth rates of pathogens during infections by D2 O-labeling lipidomics.

Neubauer C, Sessions AL, Booth IR, Bowen BP, Kopf SH, Newman DK, Dalleska NF.

Rapid Commun Mass Spectrom. 2018 Dec 30;32(24):2129-2140. doi: 10.1002/rcm.8288.

PMID:
30252972
14.

[Cystic fibrosis : A new disease pattern in adult medicine].

Staab D, Schwarz C.

Internist (Berl). 2018 Nov;59(11):1138-1145. doi: 10.1007/s00108-018-0498-y. Review. German.

PMID:
30229366
15.

Mechanism of Fibrosis in HNF1B-Related Autosomal Dominant Tubulointerstitial Kidney Disease.

Chan SC, Zhang Y, Shao A, Avdulov S, Herrera J, Aboudehen K, Pontoglio M, Igarashi P.

J Am Soc Nephrol. 2018 Oct;29(10):2493-2509. doi: 10.1681/ASN.2018040437. Epub 2018 Aug 10.

PMID:
30097458
16.

Transition and transfer of young people with cystic fibrosis to adult care.

Bowmer G, Sowerby C, Duff A.

Nurs Child Young People. 2018 Sep 10;30(5):34-39. doi: 10.7748/ncyp.2018.e1080. Epub 2018 Aug 4.

PMID:
30088702
17.

Induced pluripotent stem cells for treating cystic fibrosis: State of the science.

Pollard BS, Pollard HB.

Pediatr Pulmonol. 2018 Nov;53(S3):S12-S29. doi: 10.1002/ppul.24118. Epub 2018 Jul 30. Review.

PMID:
30062693
18.

Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology.

Rout-Pitt N, Farrow N, Parsons D, Donnelley M.

Respir Res. 2018 Jul 18;19(1):136. doi: 10.1186/s12931-018-0834-8. Review.

19.

The OmpR Regulator of Burkholderia multivorans Controls Mucoid-to-Nonmucoid Transition and Other Cell Envelope Properties Associated with Persistence in the Cystic Fibrosis Lung.

Silva IN, Pessoa FD, Ramires MJ, Santos MR, Becker JD, Cooper VS, Moreira LM.

J Bacteriol. 2018 Aug 10;200(17). pii: e00216-18. doi: 10.1128/JB.00216-18. Print 2018 Sep 1.

20.

Ready, Steady, Go - Achieving successful transition in cystic fibrosis.

Connett GJ, Nagra A.

Paediatr Respir Rev. 2018 Jun;27:13-15. doi: 10.1016/j.prrv.2018.05.007. Epub 2018 May 18. Review.

PMID:
29914748

Supplemental Content

Loading ...
Support Center